3 Beaten-Down Biotechs That Should Head Up

After a rough start to the holiday-shortened trading week, the biotech sector managed to post a solid gain along with most of the market. Oncology names got a boost from the 53rd Annual American Society of Clinical Oncology, commonly known as the ASCO conference, which opened in Chicago on Friday. The big conference runs through Tuesday and could continue to be a tailwind for this subsector of biotech.

The sector is now back once again to the top of the relatively tight trading range that it has been stuck in for most of 2017. This upward resistance level has been firmly in place since the very end of 2015. Unless merger-and-acquisition activity picks up in a significant way, I think the sector could be stymied once more to break out of this trading range....387 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money Pro trading floor.

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please login.

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.